DE3234697A1 - Neue diazabicyclo-(3,3,1)-nonane - Google Patents

Neue diazabicyclo-(3,3,1)-nonane

Info

Publication number
DE3234697A1
DE3234697A1 DE19823234697 DE3234697A DE3234697A1 DE 3234697 A1 DE3234697 A1 DE 3234697A1 DE 19823234697 DE19823234697 DE 19823234697 DE 3234697 A DE3234697 A DE 3234697A DE 3234697 A1 DE3234697 A1 DE 3234697A1
Authority
DE
Germany
Prior art keywords
compounds according
alkyl
diazabicyclo
carbon atoms
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823234697
Other languages
German (de)
English (en)
Inventor
Gerd 3000 Hannover Buschmann
Bernd Dipl.-Chem. Dr. 3004 Isernhagen Hachmeister
Wolfgang Dipl.-Chem. Dr. 3000 Hannover Kehrbach
Ulrich 3007 Gehrden Kühl
Uwe Dipl.-Chem. Dr. 3000 Hannover Schön
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Pharmaceuticals GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Priority to DE19823234697 priority Critical patent/DE3234697A1/de
Priority to ZA836185A priority patent/ZA836185B/xx
Priority to JP58154236A priority patent/JPS5970686A/ja
Priority to DD83254711A priority patent/DD213923A5/de
Priority to AT87108007T priority patent/ATE69817T1/de
Priority to EP87108007A priority patent/EP0250903B1/de
Priority to EP83108990A priority patent/EP0103833B1/de
Priority to AT83108990T priority patent/ATE45579T1/de
Priority to DE8383108990T priority patent/DE3380409D1/de
Priority to DE8787108007T priority patent/DE3382466D1/de
Priority to HU833182A priority patent/HU191096B/hu
Priority to UA3646751A priority patent/UA817A1/uk
Priority to IL69751A priority patent/IL69751A/xx
Priority to IE2186/83A priority patent/IE57580B1/en
Priority to AU19206/83A priority patent/AU564910B2/en
Priority to US06/532,762 priority patent/US4550112A/en
Priority to SU833646751A priority patent/SU1272989A3/ru
Priority to DK422583A priority patent/DK165833C/da
Priority to CA000436831A priority patent/CA1254209A/en
Priority to NZ205627A priority patent/NZ205627A/en
Priority to GR72462A priority patent/GR78722B/el
Priority to PH29556A priority patent/PH20768A/en
Priority to ES525653A priority patent/ES8405398A1/es
Priority to NO833346A priority patent/NO160516C/no
Priority to PT77344A priority patent/PT77344B/pt
Priority to FI833339A priority patent/FI76338C/fi
Publication of DE3234697A1 publication Critical patent/DE3234697A1/de
Priority to US07/054,868 priority patent/US4742172A/en
Priority to CA000579322A priority patent/CA1259998A/en
Priority to JP3308735A priority patent/JPH0670056B2/ja
Priority to CS913898A priority patent/CS389891A3/cs
Priority to MX9202996A priority patent/MX9202996A/es
Priority to LV920132A priority patent/LV5139A3/xx
Priority to LTRP154A priority patent/LT2012B/xx
Priority to GEAP1993774A priority patent/GEP19960316B/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Oxide Ceramics (AREA)
DE19823234697 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane Withdrawn DE3234697A1 (de)

Priority Applications (34)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane
ZA836185A ZA836185B (en) 1982-09-18 1983-08-22 Diazabicyclo-(3.3.1)-nonanes
JP58154236A JPS5970686A (ja) 1982-09-18 1983-08-25 新規ジアザビシクロ−（３，３，１）−ノナンその製法およびこれを含有する抗不整脈作用を有する医薬
DD83254711A DD213923A5 (de) 1982-09-18 1983-09-09 Verfahren zur herstellung neuer diazabicyclo-(3,3,1)-nonane
AT87108007T ATE69817T1 (de) 1982-09-18 1983-09-12 Tetraoxodiazabicyclo-(3,3,1)-nonane.
EP87108007A EP0250903B1 (de) 1982-09-18 1983-09-12 Tetraoxodiazabicyclo-(3,3,1)-nonane
EP83108990A EP0103833B1 (de) 1982-09-18 1983-09-12 Diazabicyclo-(3,3,1)-nonane
AT83108990T ATE45579T1 (de) 1982-09-18 1983-09-12 Diazabicyclo-(3,3,1)-nonane.
DE8383108990T DE3380409D1 (de) 1982-09-18 1983-09-12 Diazabicyclo(3.3.1)nonanes
DE8787108007T DE3382466D1 (de) 1982-09-18 1983-09-12 Tetraoxodiazabicyclo-(3,3,1)-nonane.
HU833182A HU191096B (en) 1982-09-18 1983-09-14 Process for producing new diazabicyclo /3.3.1/ nonane derivatives
DK422583A DK165833C (da) 1982-09-18 1983-09-16 Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner
PT77344A PT77344B (en) 1982-09-18 1983-09-16 Process for the preparation of new diazabicyclo-3,3,1-nonanes
IE2186/83A IE57580B1 (en) 1982-09-18 1983-09-16 New diazabicyclo-(3.3.1)-nonanes
AU19206/83A AU564910B2 (en) 1982-09-18 1983-09-16 Diazabicyclo-(3.3.1)nonanes
US06/532,762 US4550112A (en) 1982-09-18 1983-09-16 3,7-Diazabicyclo(3,3,1)nonane compounds and their use in treating heart disease
SU833646751A SU1272989A3 (ru) 1982-09-18 1983-09-16 Способ получени диазабицикло (3,3,1) нонанов
UA3646751A UA817A1 (uk) 1982-09-18 1983-09-16 Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів
CA000436831A CA1254209A (en) 1982-09-18 1983-09-16 3,7-DIAZA-BICYCLO-(3,3,1)-NONANE COMPOUNDS; COMPOSITIONS CONTAINING THEM; PREPARATION AND USE
NZ205627A NZ205627A (en) 1982-09-18 1983-09-16 Diazabicyclo-(3.3.1)-nonanes and pharmaceutical compositions
GR72462A GR78722B (enExample) 1982-09-18 1983-09-16
PH29556A PH20768A (en) 1982-09-18 1983-09-16 New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof
ES525653A ES8405398A1 (es) 1982-09-18 1983-09-16 Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
NO833346A NO160516C (no) 1982-09-18 1983-09-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye diazabicyclo-(3,3,1)-nonaner.
IL69751A IL69751A (en) 1982-09-18 1983-09-16 Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them
FI833339A FI76338C (fi) 1982-09-18 1983-09-19 Foerfarande foer framstaellning av farmakologiskt verkande diazabicyklo-(3,3,1)-nonaner.
US07/054,868 US4742172A (en) 1982-09-18 1987-05-27 Intermediates for synthesizing pharmaceutically active 3,7-diazabicyclo-(3,3,1)-nonane compounds
CA000579322A CA1259998A (en) 1982-09-18 1988-10-04 2,4,6,8-tetra-oxo-3,7-diaza bicyclo-(3,3,1)-nonane compounds
JP3308735A JPH0670056B2 (ja) 1982-09-18 1991-11-25 新規テトラオキソ−ジアザビシクロ−（３，３，１）−ノナンおよびその製法
CS913898A CS389891A3 (en) 1982-09-18 1991-12-19 Diazabicyclo-(3,3,1)-nonanes
MX9202996A MX9202996A (es) 1982-09-18 1992-06-18 Diazabiciclo-(3-3-1)nonanos.
LV920132A LV5139A3 (lv) 1982-09-18 1992-09-24 Panemiens diazabiciklo-(3,3,1)-nonanu iegusanai
LTRP154A LT2012B (lt) 1982-09-18 1992-10-14 Diazabiciklo (3,3,1) nonanu gavimo budas
GEAP1993774A GEP19960316B (en) 1982-09-18 1993-05-19 Method for Production of Diazabicyclo [3,3,1] nonanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (1)

Publication Number Publication Date
DE3234697A1 true DE3234697A1 (de) 1984-03-22

Family

ID=6173602

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19823234697 Withdrawn DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane
DE8787108007T Expired - Lifetime DE3382466D1 (de) 1982-09-18 1983-09-12 Tetraoxodiazabicyclo-(3,3,1)-nonane.
DE8383108990T Expired DE3380409D1 (de) 1982-09-18 1983-09-12 Diazabicyclo(3.3.1)nonanes

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE8787108007T Expired - Lifetime DE3382466D1 (de) 1982-09-18 1983-09-12 Tetraoxodiazabicyclo-(3,3,1)-nonane.
DE8383108990T Expired DE3380409D1 (de) 1982-09-18 1983-09-12 Diazabicyclo(3.3.1)nonanes

Country Status (25)

Country Link
US (2) US4550112A (enExample)
EP (2) EP0250903B1 (enExample)
JP (2) JPS5970686A (enExample)
AT (2) ATE69817T1 (enExample)
AU (1) AU564910B2 (enExample)
CA (1) CA1254209A (enExample)
CS (1) CS389891A3 (enExample)
DD (1) DD213923A5 (enExample)
DE (3) DE3234697A1 (enExample)
DK (1) DK165833C (enExample)
ES (1) ES8405398A1 (enExample)
FI (1) FI76338C (enExample)
GE (1) GEP19960316B (enExample)
GR (1) GR78722B (enExample)
HU (1) HU191096B (enExample)
IE (1) IE57580B1 (enExample)
IL (1) IL69751A (enExample)
MX (1) MX9202996A (enExample)
NO (1) NO160516C (enExample)
NZ (1) NZ205627A (enExample)
PH (1) PH20768A (enExample)
PT (1) PT77344B (enExample)
SU (1) SU1272989A3 (enExample)
UA (1) UA817A1 (enExample)
ZA (1) ZA836185B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771044A (en) * 1985-08-21 1988-09-13 Kali-Chemie Pharma Gmbh Tetraoxo compounds and pharmaceutical compositions

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) * 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
RU2228934C1 (ru) * 2003-05-20 2004-05-20 ООО "Исследовательский институт химического разнообразия" Замещенные 3,7-диазобицикло[3.3.1]нонаны, фокусированная библиотека и комбинаторная библиотека
CN1822833A (zh) * 2003-07-21 2006-08-23 索尔瓦药物有限公司 3,7－二氮杂双环[3,3,1]壬烷化合物在治疗和/或预防男性患者心律失常中的用途
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
KR20080021114A (ko) * 2005-06-13 2008-03-06 아스트라제네카 아베 심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76173A1 (enExample) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771044A (en) * 1985-08-21 1988-09-13 Kali-Chemie Pharma Gmbh Tetraoxo compounds and pharmaceutical compositions

Also Published As

Publication number Publication date
ES525653A0 (es) 1984-06-01
PT77344B (en) 1986-03-11
AU1920683A (en) 1984-03-22
GR78722B (enExample) 1984-10-02
DD213923A5 (de) 1984-09-26
NO160516B (no) 1989-01-16
CA1254209A (en) 1989-05-16
PH20768A (en) 1987-04-10
NO833346L (no) 1984-03-19
GEP19960316B (en) 1996-06-24
FI76338B (fi) 1988-06-30
FI833339A0 (fi) 1983-09-19
CS389891A3 (en) 1992-07-15
AU564910B2 (en) 1987-09-03
ES8405398A1 (es) 1984-06-01
JPS5970686A (ja) 1984-04-21
IE832186L (en) 1984-03-18
ZA836185B (en) 1984-04-25
NO160516C (no) 1989-04-26
IL69751A0 (en) 1983-12-30
US4550112A (en) 1985-10-29
DK165833B (da) 1993-01-25
JPH05247039A (ja) 1993-09-24
ATE69817T1 (de) 1991-12-15
EP0103833B1 (de) 1989-08-16
UA817A1 (uk) 1993-12-15
CA1259998C (enExample) 1989-09-26
IE57580B1 (en) 1993-01-13
DK422583A (da) 1984-03-19
DK165833C (da) 1993-06-21
EP0250903A3 (en) 1988-03-09
DE3380409D1 (de) 1989-09-21
MX9202996A (es) 1992-07-01
US4742172A (en) 1988-05-03
EP0103833A3 (en) 1984-11-28
FI833339L (fi) 1984-03-19
IL69751A (en) 1986-10-31
ATE45579T1 (de) 1989-09-15
DE3382466D1 (de) 1992-01-09
DK422583D0 (da) 1983-09-16
FI76338C (fi) 1988-10-10
HU191096B (en) 1987-01-28
JPH0670056B2 (ja) 1994-09-07
PT77344A (en) 1983-10-01
EP0103833A2 (de) 1984-03-28
NZ205627A (en) 1985-11-08
EP0250903B1 (de) 1991-11-27
SU1272989A3 (ru) 1986-11-23
EP0250903A2 (de) 1988-01-07

Similar Documents

Publication Publication Date Title
EP0103833B1 (de) Diazabicyclo-(3,3,1)-nonane
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0204269B1 (de) Pyridin-Derivate, ihre Herstellung und Verwendung
DE2707048C2 (de) 2-Alkyl-3-Benzoyl-Indolizinderivate, Verfahren zu deren Herstellung, sowie diese enthaltende Zusammensetzungen
DE2818672A1 (de) Alpha-(1-r-3-azetidinyl)-alpha- phenyl-alpha-substituierte-acetamide oder -acetonitrile, verfahren zu ihrer herstellung und verwendung zur behandlung von herzarrhythmien
EP0074014B1 (de) 2-(2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, seine Säureadditionssalze, Verfahren zu seiner Herstellung und Arzneimittel
EP0019172B1 (de) 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
DE2141818A1 (de) 2-phenylimino-imidazolidine, deren saeureadditionssalze und verfahren zu deren herstellung
DE1670305C3 (de) 5-Phenyl-2,4-dioxo-1,2,3,4-tetrahydro-3H-1,5-benzodiazepine und Verfahren zu ihrer Herstellung
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE3226921C2 (de) Neue 3,7-Diazabicyclo[3.3.1]nonan Verbindungen und Verfahren zu ihrer Herstellung
DE3134672A1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
DE2730593A1 (de) Neue aminoalkoxybenzofurane, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
DE3026584A1 (de) 10-halogen-14-oxon-15-hydroxy-e-homoeburnanderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2542702C2 (de) Verfahren zur Herstellung von 1-Benzoyl-2-(2,6-dichlorphenylamino)-2-imidazolin
DE2459630C3 (de) 2-Pyrimidyl-aminomethylergolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Mittel
DE2831671A1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
EP0019157A1 (de) 5,6-Dihydro-11-alkylen-morphantridin-6-one und Verfahren zu ihrer Herstellung
DE2356005A1 (de) Neue 7-amino-imidazo eckige klammer auf 1,2-a eckige klammer zu pyrimidine, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
DD153549A5 (de) Verfahren zur herstellung von pyridinderivaten
EP0014996B1 (de) Heterocyclische spiroverknüpfte Amidine, ihre Stereoisomeren und optischen Isomeren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2733064A1 (de) Vincan und seine saeureadditionssalze und quaternaeren vincaniumsalze, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
AT379810B (de) Verfahren zur herstellung von neuen 3,7-diazabicyclo (3,3,1) nonanderivaten, deren stereoisomeren und physiologisch vertraeglichen saeureadditionssalzen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal